Experts call as one for stem cell therapies’ inclusion in flagship wellness program
New Delhi: Cellular therapies being envisioned as future of medicine, its inclusion in Ayushman Bharat may prove a game changer. Evidences of successes in curing even terminal illnesses piling up point to a steady advancement in regenerative medicine. Top notch stem cell experts and scientists congregating in Delhi called in voice for the inclusion of cell based therapies in Ayushman Bharat. They also proclaimed that India is all poised to be global leader in this domain.
The two day 17th Annual Conference of the International Association of Neurorestoratology (IANR), held jointly with the 7th Annual Conference of the Society of Regenerative Sciences (India), at The Ashok Hotel starting October 17 here underlined the huge potential cell based therapies contain. It brought together over 500 doctors, scientists, and patient representatives from India and abroad to deliberate on the latest advancements in regenerative medicine and neurorestoratology.
Jual Oram, Union Minister of Tribal Affairs, inaugurated the conference, highlighting the transformative potential of scientific innovation in healthcare and commending Indian researchers for positioning India as a global leader in regenerative medicine.
J.P. Nadda, Union Minister of Health and Family Welfare, extended his greetings through a video message, saying, “India is emerging as a global leader in regenerative medicine, with its doctors at the forefront of stem cell and cellular therapy innovation. Conferences like this bring together knowledge, experience, and policy guidance to inspire young professionals and deliver real solutions for patients.”
The conference centered on regenerative medicine using cellular therapy, which restores damaged tissues and improves functional recovery in patients with neurological, orthopedic, and other difficult-to-treat disorders. With over 2.68 crore Divyang citizens in India, delegates stressed that these therapies could greatly enhance the quality of life for patients previously considered untreatable.
Ashok Sharma, representing the Society of Regenerative Sciences, said, “Our work in regenerative medicine using cellular therapy offers treatment for patients with no other options. India leads globally in research, and PM Modi has supported this initiative from the start, promoting stem cell centers and international collaboration. We urge the inclusion of cellular therapies under Ayushman Bharat so all patients can access these life-changing treatments.”
Dr. Hongyun Huang, Founding President of IANR, said, “We are grateful for the support of the Indian government and the hard work of our professors and technical teams. The aim of neural research is to restore neurological function, improve patients’ cardio-rhythm, and enhance their overall quality of life. Our findings already show significant improvements, and with continued research and collaboration, we can make these therapies more widely available and effective.”
Delegates from the USA, China, Poland, South Korea, Argentina, Hong Kong, and other countries are participating. Day 1 included discussions on clinical neurorestoration trends, stem cell interventions, and policy frameworks to support regenerative medicine in India.
The conference also marked the release of “Regenerative Medicine: The Indian Experience — India’s Global Leadership in Evidence-Based Cell/Stem Cell Therapy”, edited by Dr. Alok Sharma, Dr. B.S. Rajput, and Dr. Vinod Jain, which compiles pioneering Indian research and clinical evidence in the field.
Doctors and patient representatives jointly appealed to the Government of India to include cellular therapies for neurological, orthopedic, and other incurable conditions under the Ayushman Bharat – Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), ensuring affordable access for all.
The conference entailed thematic sessions, panel discussions, and international presentations on clinical translation and policy frameworks in regenerative and restorative medicine.
